Literature DB >> 25159452

Epidemiology of inflammatory bowel disease in Québec: recent trends.

Alain Bitton1, Maria Vutcovici, Valérie Patenaude, Maida Sewitch, Samy Suissa, Paul Brassard.   

Abstract

BACKGROUND: Among 10 provinces in Canada, Québec has the second highest incidence of Crohn's disease (CD), based on data collected more than a decade ago. To date, there are no reports on the occurrence of ulcerative colitis (UC) and no updates on the occurrence of CD in Québec. We sought to describe trends in the annual incidence and prevalence of inflammatory bowel disease in Québec during 2001 to 2008.
METHODS: A population-based retrospective cohort study was conducted using the administrative health databases of Québec. IBD cases were identified using a validated case definition requiring at least 1 hospitalization or 4 physician claims within a 2-year period. Incident cases were defined as individuals who had been free of inflammatory bowel disease for at least 2 years before the 2-year time span of the case definition.
RESULTS: We identified 24,377 CD and 15,346 UC cases. The mean age at diagnosis was 39 and 46 years for CD and UC, respectively. There was a significant decline in the annual incidence from 2001 to 2008 for both CD (P < 0.003) and UC (P < 0.001). No significant change with time was found in pediatric cases. The point prevalence in 2008 was 277 CD and 164 UC cases per 100,000 population. The average incidence was 17.4 CD cases per 100,000 person-years and 10.1 UC cases per 100,000 person-years. There was no predominance of urban or rural cases for either CD or UC.
CONCLUSIONS: During 2001 to 2008, annual incidence for both CD and UC declined in Québec. There was no significant change with time in incidence for pediatric cases.

Entities:  

Mesh:

Year:  2014        PMID: 25159452     DOI: 10.1097/MIB.0000000000000162

Source DB:  PubMed          Journal:  Inflamm Bowel Dis        ISSN: 1078-0998            Impact factor:   5.325


  15 in total

Review 1.  The global burden of IBD: from 2015 to 2025.

Authors:  Gilaad G Kaplan
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2015-09-01       Impact factor: 46.802

Review 2.  Characterization of inflammatory bowel disease in elderly patients: A review of epidemiology, current practices and outcomes of current management strategies.

Authors:  Peter Stepaniuk; Charles N Bernstein; Laura E Targownik; Harminder Singh
Journal:  Can J Gastroenterol Hepatol       Date:  2015-06-12

3.  How to explain recent multiple reports on the decline of inflammatory bowel disease in Canada.

Authors:  Xiaofa Qin
Journal:  Can J Gastroenterol Hepatol       Date:  2014-12

4.  Update on the Incidence and Prevalence of Inflammatory Bowel Disease in the United States.

Authors:  Edward V Loftus
Journal:  Gastroenterol Hepatol (N Y)       Date:  2016-11

Review 5.  The Natural History of IBD: Lessons Learned.

Authors:  Petra Weimers; Pia Munkholm
Journal:  Curr Treat Options Gastroenterol       Date:  2018-03

6.  Baicalin alleviates TNBS-induced colitis by inhibiting PI3K/AKT pathway activation.

Authors:  Lei Zhu; Hong Shen; Pei-Qing Gu; Ya-Jun Liu; Lu Zhang; Jia-Fei Cheng
Journal:  Exp Ther Med       Date:  2020-05-06       Impact factor: 2.447

7.  Trends in Epidemiology of Pediatric Inflammatory Bowel Disease in Canada: Distributed Network Analysis of Multiple Population-Based Provincial Health Administrative Databases.

Authors:  Eric I Benchimol; Charles N Bernstein; Alain Bitton; Matthew W Carroll; Harminder Singh; Anthony R Otley; Maria Vutcovici; Wael El-Matary; Geoffrey C Nguyen; Anne M Griffiths; David R Mack; Kevan Jacobson; Nassim Mojaverian; Divine Tanyingoh; Yunsong Cui; Zoann J Nugent; Janie Coulombe; Laura E Targownik; Jennifer L Jones; Desmond Leddin; Sanjay K Murthy; Gilaad G Kaplan
Journal:  Am J Gastroenterol       Date:  2017-04-18       Impact factor: 10.864

8.  Development and validation of novel algorithms to identify patients with inflammatory bowel diseases in Israel: an epi-IIRN group study.

Authors:  Mira Y Friedman; Maya Leventer-Roberts; Joseph Rosenblum; Nir Zigman; Iris Goren; Vered Mourad; Natan Lederman; Nurit Cohen; Eran Matz; Doron Z Dushnitzky; Nirit Borovsky; Moshe B Hoshen; Gili Focht; Malka Avitzour; Yael Shachar; Yehuda Chowers; Rami Eliakim; Shomron Ben-Horin; Shmuel Odes; Doron Schwartz; Iris Dotan; Eran Israeli; Zohar Levi; Eric I Benchimol; Ran D Balicer; Dan Turner
Journal:  Clin Epidemiol       Date:  2018-06-07       Impact factor: 4.790

9.  Annual Incidence and Phenotypic Presentation of IBD in Southern New Zealand: An 18-Year Epidemiological Analysis.

Authors:  Kirsten J Coppell; Ciarán P-C Galts; Fokko Y Huizing; Joanna K Norton; Andrew R Gray; Kim Schultz; Catherine E Hobbs; Kristina Aluzaite; Michael Schultz
Journal:  Inflamm Intest Dis       Date:  2018-09-17

Review 10.  Current global trends in the incidence of pediatric-onset inflammatory bowel disease.

Authors:  Josef Sýkora; Renáta Pomahačová; Marcela Kreslová; Dominika Cvalínová; Přemysl Štych; Jan Schwarz
Journal:  World J Gastroenterol       Date:  2018-07-07       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.